87/100B166.870
USD
-0.73
(-0.44%)
Pre Open·168.040USD+1.170(+0.70%)
Last updated: · Delayed 15 min
Gilead Sciences price to sales (P/S) ratioWhat is the P/S ratio? The price-to-sales ratio compares a company's market value with its revenue over the last year: what you pay for each dollar of sales.
Gilead Sciences's P/S ratio is 6.68: its market cap of 206.98B USD over revenue of 30.99B USD in the last twelve months.
- Today
- 6.68
- Average, 5 years
- 4.10
- Low, 5 years
- 2.64
- High, 5 years
- 6.99
P/S ratio = market cap ÷ revenue (last 12 months) = 206.98B ÷ 30.99B = 6.68
Each day's market cap over the revenue of the last four quarters reported by that day.
P/S ratio by year and by quarter
| Fiscal year | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Today | 6.68 | 206.98B | 30.99B | |
| FY2025 | 31 Dec 2025 | 5.19 | 152.69B | 29.44B |
| FY2024 | 31 Dec 2024 | 4.01 | 115.19B | 28.75B |
| FY2023 | 31 Dec 2023 | 3.73 | 101.10B | 27.12B |
| FY2022 | 31 Dec 2022 | 3.95 | 107.74B | 27.28B |
| FY2021 | 31 Dec 2021 | 3.34 | 91.20B | 27.31B |
| FY2020 | 31 Dec 2020 | 2.97 | 73.23B | 24.69B |
| FY2019 | 31 Dec 2019 | 3.68 | 82.52B | 22.45B |
| FY2018 | 31 Dec 2018 | 3.67 | 81.19B | 22.13B |
| FY2017 | 31 Dec 2017 | 3.59 | 93.63B | 26.11B |
| FY2016 | 31 Dec 2016 | 3.16 | 95.89B | 30.39B |
| FY2015 | 31 Dec 2015 | 4.54 | 148.14B | 32.64B |
| FY2014 | 31 Dec 2014 | 5.76 | 143.46B | 24.89B |
| FY2013 | 31 Dec 2013 | 10.25 | 114.80B | 11.20B |
| FY2012 | 31 Dec 2012 | 5.73 | 55.63B | 9.70B |
| FY2011 | 31 Dec 2011 | 3.78 | 31.71B | 8.39B |
| FY2010 | 31 Dec 2010 | 3.90 | 31.02B | 7.95B |
| FY2009 | 31 Dec 2009 | 5.58 | 39.15B | 7.01B |
| FY2008 | 31 Dec 2008 | 8.82 | 47.08B | 5.34B |
| FY2007 | 31 Dec 2007 | 10.10 | 42.74B | 4.23B |
| FY2006 | 31 Dec 2006 | 9.85 | 29.81B | 3.03B |
| FY2005 | 31 Dec 2005 | 11.77 | 23.88B | 2.03B |
| FY2004 | 31 Dec 2004 | 11.41 | 15.12B | 1.32B |
| FY2003 | 31 Dec 2003 | 13.51 | 11.73B | 867.86M |
| FY2002 | 31 Dec 2002 | 14.24 | 6.65B | 466.79M |
| FY2001 | 31 Dec 2001 | 26.76 | 6.26B | 233.77M |
| FY2000 | 31 Dec 2000 | 19.29 | 3.77B | 195.56M |
| FY1999 | 31 Dec 1999 | 13.70 | 2.32B | 169.00M |
| FY1998 | 31 Dec 1998 | 11.12 | 1.68B | 151.10M |
| FY1997 | 31 Dec 1997 | 9.43 | 1.25B | 132.30M |
| FY1996 | 31 Dec 1996 | 20.80 | 694.65M | 33.40M |
| FY1995 | 31 Dec 1995 | 252.14 | 680.77M | 2.70M |
| FY1994 | 31 Dec 1994 | 36.11 | 176.92M | 4.90M |
| FY1992 | 31 Dec 1992 | 73.44 | 308.44M | 4.20M |
| FY1991 | 31 Dec 1991 | 81.36 | 227.81M | 2.80M |
| FY1990 | 31 Dec 1990 | 148.35 | 192.86M | 1.30M |
| Quarter | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 5.97 | 185.12B | 30.99B |
| Q2 FY2026 | 30 Jun 2026 | 5.16 | 157.04B | 30.46B |
| Q1 FY2026 | 31 Mar 2026 | 5.82 | 173.10B | 29.73B |
| Q4 FY2025 | 31 Dec 2025 | 5.18 | 152.44B | 29.44B |
| Q3 FY2025 | 30 Sept 2025 | 4.74 | 137.97B | 29.09B |
| Q2 FY2025 | 30 Jun 2025 | 4.78 | 138.03B | 28.86B |
| Q1 FY2025 | 31 Mar 2025 | 4.86 | 139.61B | 28.73B |
| Q4 FY2024 | 31 Dec 2024 | 4.01 | 115.28B | 28.75B |
| Q3 FY2024 | 30 Sept 2024 | 3.69 | 104.55B | 28.30B |
| Q2 FY2024 | 30 Jun 2024 | 3.08 | 85.59B | 27.80B |
| Q1 FY2024 | 31 Mar 2024 | 3.31 | 90.88B | 27.45B |
| Q4 FY2023 | 31 Dec 2023 | 3.73 | 101.10B | 27.12B |
| Q3 FY2023 | 30 Sept 2023 | 3.41 | 93.53B | 27.39B |
| Q2 FY2023 | 30 Jun 2023 | 3.52 | 96.26B | 27.38B |
| Q1 FY2023 | 31 Mar 2023 | 3.83 | 103.55B | 27.04B |
| Q4 FY2022 | 31 Dec 2022 | 3.94 | 107.48B | 27.28B |
| Q3 FY2022 | 30 Sept 2022 | 2.85 | 77.42B | 27.14B |
| Q2 FY2022 | 30 Jun 2022 | 2.82 | 77.63B | 27.52B |
| Q1 FY2022 | 31 Mar 2022 | 2.72 | 74.61B | 27.47B |
| Q4 FY2021 | 31 Dec 2021 | 3.34 | 91.20B | 27.31B |
| Q3 FY2021 | 30 Sept 2021 | 3.19 | 87.73B | 27.48B |
| Q2 FY2021 | 30 Jun 2021 | 3.24 | 86.42B | 26.64B |
| Q1 FY2021 | 31 Mar 2021 | 3.18 | 81.18B | 25.56B |
| Q4 FY2020 | 31 Dec 2020 | 2.96 | 73.12B | 24.69B |
| Q3 FY2020 | 30 Sept 2020 | 3.43 | 79.30B | 23.15B |
| Q2 FY2020 | 30 Jun 2020 | 4.35 | 96.56B | 22.17B |
| Q1 FY2020 | 31 Mar 2020 | 4.15 | 94.35B | 22.72B |
| Q4 FY2019 | 31 Dec 2019 | 3.66 | 82.26B | 22.45B |
| Q3 FY2019 | 30 Sept 2019 | 3.59 | 80.26B | 22.37B |
| Q2 FY2019 | 30 Jun 2019 | 3.85 | 86.14B | 22.36B |
| Q1 FY2019 | 31 Mar 2019 | 3.77 | 84.06B | 22.32B |
| Q4 FY2018 | 31 Dec 2018 | 3.65 | 80.69B | 22.13B |
| Q3 FY2018 | 30 Sept 2018 | 4.53 | 101.04B | 22.28B |
| Q2 FY2018 | 30 Jun 2018 | 3.96 | 91.95B | 23.20B |
| Q1 FY2018 | 31 Mar 2018 | 3.99 | 98.53B | 24.69B |
| Q4 FY2017 | 31 Dec 2017 | 3.59 | 93.63B | 26.11B |
| Q3 FY2017 | 30 Sept 2017 | 3.85 | 105.81B | 27.48B |
| Q2 FY2017 | 30 Jun 2017 | 3.25 | 92.51B | 28.47B |
| Q1 FY2017 | 31 Mar 2017 | 3.05 | 88.84B | 29.10B |
| Q4 FY2016 | 31 Dec 2016 | 3.10 | 94.24B | 30.39B |
| Q3 FY2016 | 30 Sept 2016 | 3.31 | 104.60B | 31.58B |
| Q2 FY2016 | 30 Jun 2016 | 3.44 | 111.37B | 32.37B |
| Q1 FY2016 | 31 Mar 2016 | 3.87 | 127.04B | 32.84B |
| Q4 FY2015 | 31 Dec 2015 | 4.45 | 145.31B | 32.64B |
| Q3 FY2015 | 30 Sept 2015 | 4.57 | 143.65B | 31.45B |
| Q2 FY2015 | 30 Jun 2015 | 5.90 | 172.34B | 29.19B |
| Q1 FY2015 | 31 Mar 2015 | 5.31 | 146.02B | 27.49B |
| Q4 FY2014 | 31 Dec 2014 | 5.70 | 141.96B | 24.89B |
| Q3 FY2014 | 30 Sept 2014 | 7.79 | 161.15B | 20.70B |
| Q2 FY2014 | 30 Jun 2014 | 7.29 | 127.08B | 17.44B |
| Q1 FY2014 | 31 Mar 2014 | 7.97 | 108.88B | 13.67B |
| Q4 FY2013 | 31 Dec 2013 | 10.28 | 115.19B | 11.20B |
| Q3 FY2013 | 30 Sept 2013 | 9.03 | 96.32B | 10.67B |
| Q2 FY2013 | 30 Jun 2013 | 7.65 | 78.88B | 10.31B |
| Q1 FY2013 | 31 Mar 2013 | 7.33 | 73.00B | 9.95B |
| Q4 FY2012 | 31 Dec 2012 | 5.74 | 55.73B | 9.70B |
| Q3 FY2012 | 30 Sept 2012 | 5.48 | 51.08B | 9.31B |
| Q2 FY2012 | 30 Jun 2012 | 4.31 | 38.82B | 9.01B |
| Q1 FY2012 | 31 Mar 2012 | 4.23 | 36.95B | 8.74B |
| Q4 FY2011 | 31 Dec 2011 | 3.60 | 30.19B | 8.39B |
| Q3 FY2011 | 30 Sept 2011 | 3.64 | 29.76B | 8.18B |
| Q2 FY2011 | 30 Jun 2011 | 4.06 | 32.51B | 8.00B |
| Q1 FY2011 | 31 Mar 2011 | 4.34 | 33.82B | 7.79B |
| Q4 FY2010 | 31 Dec 2010 | 3.69 | 29.30B | 7.95B |
| Q3 FY2010 | 30 Sept 2010 | 3.72 | 29.67B | 7.98B |
| Q2 FY2010 | 30 Jun 2010 | 3.85 | 30.23B | 7.85B |
| Q1 FY2010 | 31 Mar 2010 | 5.42 | 41.01B | 7.57B |
| Q4 FY2009 | 31 Dec 2009 | 5.55 | 38.94B | 7.01B |
| Q3 FY2009 | 30 Sept 2009 | 6.56 | 42.00B | 6.41B |
| Q2 FY2009 | 30 Jun 2009 | 7.10 | 42.42B | 5.98B |
| Q1 FY2009 | 31 Mar 2009 | 7.51 | 42.14B | 5.61B |
| Q4 FY2008 | 31 Dec 2008 | 8.73 | 46.59B | 5.34B |
| Q3 FY2008 | 30 Sept 2008 | 8.40 | 42.03B | 5.00B |
| Q2 FY2008 | 30 Jun 2008 | 10.42 | 48.87B | 4.69B |
| Q1 FY2008 | 31 Mar 2008 | 10.73 | 47.83B | 4.46B |
| Q4 FY2007 | 31 Dec 2007 | 10.08 | 42.64B | 4.23B |
| Q3 FY2007 | 30 Sept 2007 | 9.62 | 38.82B | 4.03B |
| Q2 FY2007 | 30 Jun 2007 | 9.71 | 36.15B | 3.72B |
| Q1 FY2007 | 31 Mar 2007 | 10.57 | 35.52B | 3.36B |
| Q4 FY2006 | 31 Dec 2006 | 9.81 | 29.70B | 3.03B |
| Q3 FY2006 | 30 Sept 2006 | 11.50 | 31.45B | 2.74B |
| Q2 FY2006 | 30 Jun 2006 | 10.91 | 27.07B | 2.48B |
| Q1 FY2006 | 31 Mar 2006 | 12.54 | 28.72B | 2.29B |
| Q4 FY2005 | 31 Dec 2005 | 11.82 | 23.97B | 2.03B |
| Q3 FY2005 | 30 Sept 2005 | 12.43 | 22.24B | 1.79B |
| Q2 FY2005 | 30 Jun 2005 | 12.29 | 19.93B | 1.62B |
| Q1 FY2005 | 31 Mar 2005 | 11.13 | 16.09B | 1.45B |
| Q4 FY2004 | 31 Dec 2004 | 11.40 | 15.09B | 1.32B |
| Q3 FY2004 | 30 Sept 2004 | 13.24 | 16.13B | 1.22B |
| Q2 FY2004 | 30 Jun 2004 | 13.16 | 14.38B | 1.09B |
| Q1 FY2004 | 31 Mar 2004 | 11.70 | 11.84B | 1.01B |
| Q4 FY2003 | 31 Dec 2003 | 13.55 | 11.76B | 867.86M |
| Q3 FY2003 | 30 Sept 2003 | 15.07 | 11.29B | 749.37M |
| Q2 FY2003 | 30 Jun 2003 | 16.28 | 11.12B | 682.99M |
| Q1 FY2003 | 31 Mar 2003 | 15.05 | 8.33B | 553.48M |
| Q4 FY2002 | 31 Dec 2002 | 14.29 | 6.67B | 466.79M |
| Q3 FY2002 | 30 Sept 2002 | 16.60 | 6.57B | 396.09M |
| Q2 FY2002 | 30 Jun 2002 | 18.90 | 5.92B | 313.03M |
| Q1 FY2002 | 31 Mar 2002 | 27.80 | 7.07B | 254.35M |
| Q4 FY2001 | 31 Dec 2001 | 26.81 | 6.27B | 233.77M |
| Q3 FY2001 | 30 Sept 2001 | 25.14 | 5.40B | 214.70M |
| Q2 FY2001 | 30 Jun 2001 | 26.43 | 5.52B | 208.88M |
| Q1 FY2001 | 31 Mar 2001 | 14.71 | 3.06B | 208.32M |
| Q4 FY2000 | 31 Dec 2000 | 19.27 | 3.82B | 198.20M |
| Q3 FY2000 | 30 Sept 2000 | 26.38 | 5.06B | 191.73M |
| Q2 FY2000 | 30 Jun 2000 | 17.12 | 3.17B | 185.04M |
| Q1 FY2000 | 31 Mar 2000 | 15.74 | 2.81B | 178.45M |
| Q4 FY1999 | 31 Dec 1999 | 13.90 | 2.35B | 169.01M |
| Q3 FY1999 | 30 Sept 1999 | 21.64 | 2.80B | 129.21M |
| Q2 FY1999 | 30 Jun 1999 | 17.90 | 2.20B | 122.71M |
| Q1 FY1999 | 31 Mar 1999 | 16.36 | 1.41B | 86.18M |
| Q4 FY1998 | 31 Dec 1998 | 20.21 | 1.24B | 61.50M |
| Q3 FY1998 | 30 Sept 1998 | 12.71 | 792.92M | 62.40M |
| Q2 FY1998 | 30 Jun 1998 | 26.76 | 947.20M | 35.40M |
| Q1 FY1998 | 31 Mar 1998 | 21.40 | 1.03B | 48.10M |
| Q4 FY1997 | 31 Dec 1997 | 27.47 | 1.10B | 40.00M |
| Q3 FY1997 | 30 Sept 1997 | 35.45 | 1.27B | 35.90M |
| Q2 FY1997 | 30 Jun 1997 | 13.99 | 779.42M | 55.70M |
| Q1 FY1997 | 31 Mar 1997 | — | 645.40M | — |
| Q4 FY1996 | 31 Dec 1996 | 20.41 | 683.82M | 33.50M |
| Q3 FY1996 | 30 Sept 1996 | — | 772.72M | — |
| Q2 FY1996 | 31 May 1996 | — | 967.13M | — |
| Q1 FY1996 | 31 Mar 1996 | — | 745.71M | — |
| Q3 FY1995 | 30 Sept 1995 | 110.00 | 462.00M | 4.20M |
| Q2 FY1995 | 30 Jun 1995 | 70.54 | 331.52M | 4.70M |
| Q1 FY1995 | 31 Mar 1995 | 49.44 | 242.27M | 4.90M |
| Q4 FY1994 | 31 Dec 1994 | 34.72 | 177.05M | 5.10M |
| Q3 FY1994 | 30 Sept 1994 | 44.17 | 216.45M | 4.90M |
| Q2 FY1994 | 30 Jun 1994 | 37.45 | 161.06M | 4.30M |
| Q1 FY1994 | 31 Mar 1994 | 46.28 | 194.36M | 4.20M |
| Q4 FY1993 | 31 Dec 1993 | 54.47 | 223.33M | 4.10M |
| Q3 FY1993 | 30 Sept 1993 | 65.70 | 262.82M | 4.00M |
| Q2 FY1993 | 30 Jun 1993 | 75.58 | 302.31M | 4.00M |
| Q1 FY1993 | 31 Mar 1993 | 44.82 | 183.75M | 4.10M |
| Q4 FY1992 | 31 Dec 1992 | 57.75 | 288.75M | 5.00M |
| Q3 FY1992 | 30 Sept 1992 | 37.50 | 168.75M | 4.50M |
| Q2 FY1992 | 30 Jun 1992 | 49.66 | 183.75M | 3.70M |
| Q1 FY1992 | 31 Mar 1992 | 89.28 | 249.98M | 2.80M |
| Q4 FY1991 | 31 Dec 1991 | 146.09 | 306.79M | 2.10M |
| Q3 FY1991 | 30 Sept 1991 | 180.46 | 306.79M | 1.70M |
| Q2 FY1991 | 30 Jun 1991 | 191.74 | 306.79M | 1.60M |
| Q1 FY1991 | 31 Mar 1991 | 121.50 | 182.25M | 1.50M |
| Q4 FY1990 | 31 Dec 1990 | — | 182.25M | — |
| Q3 FY1990 | 30 Sept 1990 | — | 168.75M | — |
| Q2 FY1990 | 30 Jun 1990 | — | 202.50M | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about Gilead Sciences's P/S ratio
Source: Financial Modeling Prep